BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 17332312)

  • 1. Notch signaling, gamma-secretase inhibitors, and cancer therapy.
    Shih IeM; Wang TL
    Cancer Res; 2007 Mar; 67(5):1879-82. PubMed ID: 17332312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational targeting of Notch signaling in cancer.
    Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
    Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of the γ-secretase-notch axis in inflammation.
    Cheng YL; Choi Y; Sobey CG; Arumugam TV; Jo DG
    Pharmacol Ther; 2015 Mar; 147():80-90. PubMed ID: 25448038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch signaling: an emerging therapeutic target for cancer treatment.
    Yuan X; Wu H; Xu H; Xiong H; Chu Q; Yu S; Wu GS; Wu K
    Cancer Lett; 2015 Dec; 369(1):20-7. PubMed ID: 26341688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-secretase and the intramembrane proteolysis of Notch.
    Jorissen E; De Strooper B
    Curr Top Dev Biol; 2010; 92():201-30. PubMed ID: 20816396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein.
    Yang T; Arslanova D; Gu Y; Augelli-Szafran C; Xia W
    Mol Brain; 2008 Nov; 1():15. PubMed ID: 18983676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecules that inhibit Notch signaling.
    De Kloe GE; De Strooper B
    Methods Mol Biol; 2014; 1187():311-22. PubMed ID: 25053499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Notch signaling pathway in esophageal adenocarcinoma.
    Wang Z; Chen J; Capobianco AJ
    Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):24-32. PubMed ID: 26518893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies.
    Nefedova Y; Gabrilovich D
    Drug Resist Updat; 2008 Dec; 11(6):210-8. PubMed ID: 18951834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor.
    Wang K; Zhang Q; Li D; Ching K; Zhang C; Zheng X; Ozeck M; Shi S; Li X; Wang H; Rejto P; Christensen J; Olson P
    Clin Cancer Res; 2015 Mar; 21(6):1487-96. PubMed ID: 25564152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.
    Kumar R; Juillerat-Jeanneret L; Golshayan D
    J Med Chem; 2016 Sep; 59(17):7719-37. PubMed ID: 27045975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials.
    Shi W; Harris AL
    J Mammary Gland Biol Neoplasia; 2006 Jan; 11(1):41-52. PubMed ID: 16947085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that gamma-secretase-mediated Notch signaling induces neuronal cell death via the nuclear factor-kappaB-Bcl-2-interacting mediator of cell death pathway in ischemic stroke.
    Arumugam TV; Cheng YL; Choi Y; Choi YH; Yang S; Yun YK; Park JS; Yang DK; Thundyil J; Gelderblom M; Karamyan VT; Tang SC; Chan SL; Magnus T; Sobey CG; Jo DG
    Mol Pharmacol; 2011 Jul; 80(1):23-31. PubMed ID: 21450930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rethinking Gamma-secretase Inhibitors for Treatment of Non-small-Cell Lung Cancer: Is Notch the Target?
    Pine SR
    Clin Cancer Res; 2018 Dec; 24(24):6136-6141. PubMed ID: 30104200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling.
    Suwanjunee S; Wongchana W; Palaga T
    Anticancer Drugs; 2008 Jun; 19(5):477-86. PubMed ID: 18418214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphenol A disrupts Notch signaling by inhibiting gamma-secretase activity and causes eye dysplasia of Xenopus laevis.
    Baba K; Okada K; Kinoshita T; Imaoka S
    Toxicol Sci; 2009 Apr; 108(2):344-55. PubMed ID: 19218331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient gamma-secretase inhibition accelerates and enhances fracture repair likely via Notch signaling modulation.
    Wang C; Shen J; Yukata K; Inzana JA; O'Keefe RJ; Awad HA; Hilton MJ
    Bone; 2015 Apr; 73():77-89. PubMed ID: 25527421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early regionalization of the otic placode and its regulation by the Notch signaling pathway.
    Abelló G; Khatri S; Giráldez F; Alsina B
    Mech Dev; 2007 Aug; 124(7-8):631-45. PubMed ID: 17532192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.